2 months ago
NBIX
AnalystsJeffrey HungJeffrey Hung's Stock Forecasts
AnalystsJeffrey Hung
Sectors:
Analyst Ranking
Top 7%
#339 out of 5312 analysts
Average Return
+17.51%
Win Rate
60%81 out of 135
Risk vs Reward
Poor
Good
Jeffrey Hung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Myokardia IncMYOK | +314.95% | $53.26 | $221.00 | 2020-04-15 - 2020-10-06 | Strong Buy |
Cytokinetics IncCYTK | +182.40% | $33.19 | $93.73 | 2023-08-04 - 2024-01-05 | Strong Buy |
Cg Oncology IncCGON | +153.14% | $24.86 | $62.93 | 2025-05-19 - 2026-05-18 | Strong Buy |
Cytokinetics IncCYTK | +151.83% | $37.22 | $93.73 | 2023-06-22 - 2024-01-05 | Strong Buy |
Cg Oncology IncCGON | +131.59% | $26.72 | $61.88 | 2025-03-07 - 2026-03-06 | Strong Buy |
Jeffrey Hung Analyst Color
Get additional color on Jeffrey Hung's coverage of popular stocks
2 months ago
CYTK
2 months ago
RARE
4 months ago
JAZZ
4 months ago
PTCT
6 months ago
NBIX
6 months ago
CYTK
7 months ago
JAZZ
8 months ago
ENGN
8 months ago
NBIX
8 months ago
JAZZ
8 months ago
RYTM
9 months ago
RYTM
9 months ago
JAZZ
9 months ago
CGON
10 months ago
JAZZ
a year ago
RYTM
a year ago
NBIX
a year ago
FOLD
a year ago
CGON
a year ago
PTCT
a year ago
JAZZ
a year ago
NBIX
2 years ago
PTCT
2 years ago
ITCI
Jeffrey Hung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Contineum Therapeutics IncCTNM | 6 | Hold | $16.00 | +12.76% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 19 | Hold | $191.00 | +13.34% | Maintains | 2 months ago |
Cytokinetics IncCYTK | 9 | Strong Buy | $103.00 | +25.32% | Maintains | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 9 | Strong Buy | $67.00 | +117.74% | Maintains | 2 months ago |
Bicycle Therapeutics PLCBCYC | 7 | Hold | $12.00 | +192.68% | Maintains | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 14 | Strong Buy | $136.00 | +23.82% | Maintains | 3 months ago |
Jazz Pharmaceuticals PLCJAZZ | 13 | Strong Buy | $226.00 | -1.75% | Maintains | 4 months ago |
Ptc Therapeutics IncPTCT | 14 | Strong Buy | $92.00 | +8.97% | Maintains | 4 months ago |
Crinetics Pharmaceuticals IncCRNX | 4 | Strong Buy | $80.00 | +117.98% | Maintains | 6 months ago |
Bioage Labs IncBIOA | 3 | Hold | $12.00 | -49.49% | Upgrades | 7 months ago |
Engene Therapeutics IncENGN | 5 | Strong Buy | $19.00 | +985.71% | Maintains | 8 months ago |
Cg Oncology IncCGON | 5 | Strong Buy | $79.00 | +9.78% | Maintains | 9 months ago |
Cullinan Therapeutics IncCGEM | 6 | Strong Buy | $28.00 | +52.17% | Maintains | 10 months ago |
Erasca IncERAS | 4 | Hold | $2.00 | -87.51% | Downgrades | 10 months ago |
Amicus Therapeutics IncFOLD | 5 | Strong Buy | $108.00 | +645.34% | Upgrades | a year ago |
Acadia Pharmaceuticals IncACAD | 20 | Hold | $24.00 | N/A | Maintains | a year ago |
Disc Medicine IncIRON | 6 | Strong Buy | $85.00 | N/A | Assumes | a year ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $27.00 | N/A | Assumes | a year ago |
Intra Cellular Therapies IncITCI | 5 | Strong Buy | $95.00 | N/A | Maintains | 2 years ago |
Cervomed IncCRVO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Hold | $330.00 | N/A | Downgrades | 3 years ago |
Prelude Therapeutics IncPRLD | 6 | Strong Sell | $4.00 | N/A | Downgrades | 3 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Sell | $4.00 | N/A | Downgrades | 3 years ago |
Invivyd IncIVVD | 1 | Hold | $4.00 | N/A | Upgrades | 3 years ago |
Bluebird Bio IncBLUE | 1 | Hold | $140.00 | N/A | Upgrades | 3 years ago |
Immuneering CorpIMRX | 3 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Esperion Therapeutics IncESPR | 7 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Repare Therapeutics IncRPTX | 5 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 4 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Cyteir Therapeutics IncCYTT | 3 | Strong Sell | $2.00 | N/A | Downgrades | 3 years ago |
Celularity IncCELU | 3 | Strong Sell | $10.00 | N/A | Downgrades | 3 years ago |
Cincor Pharma IncCINC | 6 | Hold | $30.00 | N/A | Maintains | 3 years ago |
Exelixis IncEXEL | 2 | Hold | $22.00 | N/A | Maintains | 4 years ago |
Rubius Therapeutics IncRUBY | 3 | Hold | $1.50 | N/A | Maintains | 4 years ago |
Evofem Biosciences IncEVFM | 6 | Strong Sell | $0.75 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $146.00 | N/A | Maintains | 4 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 5 years ago |
Aprea Therapeutics IncAPRE | 5 | Strong Sell | $60.00 | N/A | Downgrades | 5 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | $7.00 | N/A | Maintains | 5 years ago |
Myokardia IncMYOK | 2 | Hold | $225.00 | N/A | Downgrades | 6 years ago |
Nextcure IncNXTC | 6 | Strong Buy | $648.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.